{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:35:01Z","timestamp":1761824101475,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.brachy.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T22:33:50Z","timestamp":1537050830000},"page":"929-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?"],"prefix":"10.1016","volume":"17","author":[{"given":"Karina","family":"Nieto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nghia","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Palmere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott R.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abigail","family":"Winder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Liotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald K.","family":"Potkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew M.","family":"Harkenrider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brachy.2018.08.005_bib2","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.brachy.2018.08.005_bib3","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study","volume":"60","author":"Creasman","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.brachy.2018.08.005_bib4","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.005_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.brachy.2018.08.005_bib7","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/IGC.0b013e3182643ba0","article-title":"External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study\u2013quality-of-life analysis","volume":"22","author":"Sorbe","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.005_bib8","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00280-013-2276-9","article-title":"Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-Eastern German Society of Gynaecological Oncology)","volume":"72","author":"Mustea","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.brachy.2018.08.005_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American Brachytherapy Task Group Report: adjuvant vaginal brachytherapy for early-stage endometrial cancer: a comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.005_bib10","first-page":"S105","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.brachy.2018.08.005_bib11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1245\/s10434-015-4583-3","article-title":"Tumor size, an additional prognostic factor to include in low-risk endometrial cancer: results of a French multicenter study","volume":"23","author":"Canlorbe","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ygyno.2013.10.023","article-title":"High-grade endometrial cancer: revisiting the impact of tumor size and location on outcomes","volume":"132","author":"Doll","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ygyno.2014.12.036","article-title":"The role of vaginal cuff brachytherapy in endometrial cancer","volume":"136","author":"Harkenrider","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.005_bib16","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1200\/JCO.2004.02.088","article-title":"Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study","volume":"22","author":"Thigpen","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ygyno.2008.08.029","article-title":"Reuse of carboplatin and paclitaxel in patients with relapsed endometrial cancer--the British Columbia Cancer Agency experience","volume":"111","author":"Mazgani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib18","first-page":"803","article-title":"Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel-long-term follow-up","volume":"18","author":"Sorbe","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.005_bib19","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/IGC.0b013e3181ad3dcb","article-title":"Leuven dose-dense paclitaxel\/carboplatin regimen in patients with primary advanced or recurrent endometrial carcinoma","volume":"19","author":"Vandenput","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.brachy.2018.08.005_bib20","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2017.09.008","article-title":"A Phase 3 trial of pelvic radiation therapy versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy in patients with high-risk, early-stage endometrial cancer: a gynecology oncology group study","volume":"99","author":"Randall","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.005_bib21","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2014.07.078","article-title":"Randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel\/carboplatin chemotherapy (VCB\/C) in patients with high risk (HR), early stage endometrial cancer (EC): a gynecologic oncology group trial","volume":"123","author":"McMeekin","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib22","series-title":"AJCC Staging Manual","first-page":"403","article-title":"Corpus uteri","year":"2010"},{"year":"2010","series-title":"Common terminology criteria for adverse events: (CTCAE)","key":"10.1016\/j.brachy.2018.08.005_bib23"},{"volume":"398","year":"2013","author":"Hosmer","key":"10.1016\/j.brachy.2018.08.005_bib24"},{"year":"2013","series-title":"Categorical data analysis","author":"Agresti","key":"10.1016\/j.brachy.2018.08.005_bib25"},{"key":"10.1016\/j.brachy.2018.08.005_bib26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","article-title":"American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy","volume":"11","author":"Small","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.005_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2011.12.010","article-title":"Clinical outcomes in FIGO stage IA endometrial cancer with myometrial invasion treated with or without postoperative vaginal Brachytherapy","volume":"84","author":"Diavolitsis","year":"2012","journal-title":"Int J Radiol Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.005_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2004.09.054","article-title":"Intravaginal brachytherapy alone for intermediate-risk endometrial cancer","volume":"62","author":"Alektiar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2018.08.005_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ygyno.2013.11.005","article-title":"Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors","volume":"132","author":"Landrum","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.brachy.2018.08.005_bib30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5114\/jcb.2014.45031","article-title":"Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer","volume":"6","author":"Eldredge-Hindy","year":"2014","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.brachy.2018.08.005_bib31","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.ejca.2011.11.014","article-title":"Five-year quality of life of endometrial cancer patients treated in the randomised post operative radiation therapy in endometrial cancer (PORTEC-2) trial and comparison with norm data","volume":"48","author":"Nout","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.brachy.2018.08.005_bib32","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/gyno.1999.5526","article-title":"Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patientstreated with postoperative vaginal vault brachytherapy","volume":"75","author":"Chadha","year":"1999","journal-title":"J Gynecol Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118301442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472118301442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:14:28Z","timestamp":1761531268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472118301442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1538472118301442"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2018.08.005","relation":{},"ISSN":["1538-4721"],"issn-type":[{"type":"print","value":"1538-4721"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Brachytherapy Society.","name":"copyright","label":"Copyright"}]}}